Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,925,883
-$4,815,822 QoQ
Shares Held
771,821
-1.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#42
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. SNY ranks #13 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,925,883 | 771,821 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $37,741,705 | 783,348 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $30,717,824 | 633,880 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $29,462,616 | 624,208 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $31,266,955 | 647,215 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,293,577 | 618,348 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $25,425,406 | 527,170 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $32,419,581 | 562,547 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,766,298 | 551,655 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $23,501,014 | 483,560 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $22,404,307 | 450,519 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $27,540,544 | 513,433 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $27,402,057 | 508,387 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,413,290 | 485,360 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,944,850 | 329,235 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,760,879 | 335,636 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,087,494 | 381,521 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,072,295 | 371,490 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,203,836 | 343,390 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,219,047 | 336,425 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,475,574 | 312,867 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,744,882 | 277,899 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,123,883 | 249,514 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,693,871 | 233,085 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,338,426 | 241,693 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,974,504 | 251,018 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||